Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -45.28
- Piotroski Score 3.00
- Grade N/A
- Symbol (PETV)
- Company PetVivo Holdings, Inc.
- Price $0.47
- Changes Percentage (-0.85%)
- Change -$0
- Day Low $0.45
- Day High $0.47
- Year High $1.50
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/14/2024
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.85
- Trailing P/E Ratio -0.8
- Forward P/E Ratio -0.8
- P/E Growth -0.8
- Net Income $-10,955,295
Income Statement
Quarterly
Annual
Latest News of PETV
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
PetVivo Holdings Inc (PETV) Q2 2025 Earnings Call Highlights: Strategic Growth Amidst Revenue ...
PetVivo Holdings has successfully raised $1.5 million through preferred stock offerings. Future revenue expectations include a growth of $1.5 million in the fiscal fourth quarter of 2025. Strategic me...
By Yahoo! Finance | 1 week ago
